دورية أكاديمية
أعرض في EDS

Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.

التفاصيل البيبلوغرافية
العنوان: Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.
المؤلفون: Hungria V; Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), São Paulo, SP, Brazil; Clínica São Germano, São Paulo, SP, Brazil., Garnica M; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil., Crusoé EQ; Hospital Universitário Professor Edgar Santos da Universidade Federal da Bahia (HUPES), Salvador, BA, Brazil; Rede D'or Oncologia, São Paulo, SP, Brazil., Magalhaes Filho RJP; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Martinez G; Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), São Paulo, SP, Brazil; Instituto do Câncer de São Paulo da Universidade de São Paulo (ICESP USP), São Paulo, SP, Brazil., Bittencourt R; Hospital de Clínicas de Porto Alegre da Universidade Federal de Porto Alegre (HCPA UFRGS), Porto Alegre, RS, Brazil., Farias DLC; Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., Braga WM; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Neto JVP; Centro de Câncer de Brasília (Cettro), Brasilia, DF, Brazil., Ribeiro GN; Hospital das Clínicas da Universidade Federal de Minas Gerais (HC-UFMG ), Belo Horizonte, MG, Brazil., Maiolino A; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Américas Centro de Oncologia Integrado, Rio de Janeiro, RJ, Brazil. Electronic address: maiolino@hucff.ufrj.br.
المصدر: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2020 Jul - Sep; Vol. 42 (3), pp. 200-205. Date of Electronic Publication: 2020 May 13.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Editora Ltda Country of Publication: Brazil NLM ID: 101725732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-1387 (Electronic) Linking ISSN: 25311379 NLM ISO Abbreviation: Hematol Transfus Cell Ther Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Rio de Janeiro, Brazil] : Elsevier Editora Ltda, [2018]-
مستخلص: Since the World has been facing the COVID-19 pandemic, special attention has been taken concerning cancer patients; related to their immunosuppression status, adding risk for more aggressive COVID-19 and mortality, but also concerns about the access and the quality of care in cancer therapy. The COVID-19 pandemic impacts the number of infected, its related mortality, as well as the care of cancer patients. Multiple myeloma patients are a particular group with several important aspects to be considered during pandemic times. In essence, they are immunosuppressed in different intensities during their treatment. Most of them are elderly and all of them require long-term therapy, with prolonged contact with the health care system, possibly including a stem cell transplant during the treatment. A panel of experts in multiple myeloma and infectious diseases discusses pieces of evidence and the lack of the same in the scenario of COVID-19 in myeloma patients, while also exposing what is expected for the next phases of the COVID-19 pandemic.
(Copyright © 2020 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights reserved.)
References: Clin Microbiol Infect. 2020 Jun;26(6):669-672. (PMID: 32278082)
Early Hum Dev. 2020 May;144:105026. (PMID: 32247898)
JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570)
Blood. 2019 Oct 17;134(16):1337-1345. (PMID: 31484647)
Haematologica. 2015 Jan;100(1):107-13. (PMID: 25344526)
Lancet Infect Dis. 2020 Jun;20(6):656-657. (PMID: 32199493)
N Engl J Med. 2020 Oct 29;383(18):1757-1766. (PMID: 32329974)
N Engl J Med. 2020 May 21;382(21):e63. (PMID: 32237672)
Clin Infect Dis. 2020 Nov 5;71(8):1947-1952. (PMID: 32315026)
Lancet Haematol. 2020 Jun;7(6):e435-e437. (PMID: 32353254)
Blood Adv. 2020 Apr 14;4(7):1307-1310. (PMID: 32243501)
J Clin Microbiol. 2020 May 26;58(6):. (PMID: 32245835)
Acta Haematol. 2020;143(5):410-416. (PMID: 32305989)
N Engl J Med. 2020 May 21;382(21):1969-1973. (PMID: 32227757)
Lancet Oncol. 2018 Jul;19(7):953-964. (PMID: 29866475)
Lancet Respir Med. 2020 Apr;8(4):420-422. (PMID: 32085846)
Lancet Haematol. 2020 Jun;7(6):e432-e435. (PMID: 32339482)
Lancet. 2020 May 2;395(10234):1417-1418. (PMID: 32325026)
J Infect. 2020 Jul;81(1):e13-e20. (PMID: 32283144)
Clin Lymphoma Myeloma Leuk. 2017 May;17(5):296-304.e2. (PMID: 28343904)
Intensive Care Med. 2020 May;46(5):846-848. (PMID: 32125452)
N Engl J Med. 2020 Jun 11;382(24):2372-2374. (PMID: 32302078)
JAMA. 2020 Apr 14;323(14):1406-1407. (PMID: 32083643)
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934. (PMID: 32306047)
Crit Care Resusc. 2020 Apr 15;22(2):95-97. (PMID: 32294809)
N Engl J Med. 2017 Apr 6;376(14):1311-1320. (PMID: 28379796)
Leukemia. 2008 Feb;22(2):414-23. (PMID: 18094721)
JAMA. 2020 May 12;323(18):1824-1836. (PMID: 32282022)
Clin Infect Dis. 2009 Oct 15;49(8):1211-25. (PMID: 19769539)
فهرسة مساهمة: Keywords: COVID-19; Multiple myeloma; SARS-CoV-2
تواريخ الأحداث: Date Created: 20200515 Latest Revision: 20210110
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC7218372
DOI: 10.1016/j.htct.2020.05.001
PMID: 32405620
قاعدة البيانات: MEDLINE
الوصف
تدمد:2531-1387
DOI:10.1016/j.htct.2020.05.001